The global atrial fibrillation devices market is estimated to grow significantly at a CAGR of 13.7% during the forecast period. The major factors contributing to the market growth include rising prevalence of atrial fibrillation coupled with the significant incidences of cardiac arrhythmias and rising demand for minimally invasive procedures. Atrial fibrillation is the most common cause of heart arrhythmia, in which, the heart beats very slowly, very fast or in an irregular way. According to the Institute for Health Metrics and Evaluation, the prevalence of atrial fibrillation in 2013 was 33.6 million, which increased up to 37.5 million in 2017. With the significant rise in geriatric population across the globe, this number is expected to increase in the near future.
Request a free sample of our report on Global Atrial Fibrillation Devices Market: https://www.omrglobal.com/request-sample/atrial-fibrillation-devices-market-size



The two major strategies used for the management of atrial fibrillation include rhythm control and rate control. Rhythm control comprises the use of electrophysiological interventions which intends to convert the arrhythmia concerned with atrial fibrillation to normal sinus rhythm. While diagnosed with atrial fibrillation, the doctor recommends an electrophysiology study to better understand the way electrical signals move in the heart to make it beat. The test enables to understand and map the electrical activity in the heart, which, in turn, contributes to diagnose abnormal heart rhythms.

A full report of Global Atrial Fibrillation Devices Market Is available at https://www.omrglobal.com/industry-reports/atrial-fibrillation-devices-market-size



Global Atrial Fibrillation Devices Market Segmentation

By Product Type

Electrophysiology Ablation Catheters

Electrophysiology Diagnostic Catheters

Electrophysiology Mapping and Recording Systems

Cardiac Monitors

Others (Intracardiac Echocardiography (ICE) Systems)

By End-Use

Hospitals and Clinics

Ambulatory Surgery Centers (ASCs)

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Company Profiles

Abbott Laboratories Inc.

Advanced Cardiac Therapeutics, Inc.

AliveCor, Inc.

AtriCure, Inc.

AuriGen Medical

BIOTRONIK SE & Co. KG

Boston Scientific Corp.

CardioFocus, Inc.

CathRx Ltd.

General Electric Co.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/atrial-fibrillation-devices-market-size



About Us:



Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404